BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 20629054)

  • 1. Targeted metabolomics for biomarker discovery.
    Griffiths WJ; Koal T; Wang Y; Kohl M; Enot DP; Deigner HP
    Angew Chem Int Ed Engl; 2010 Jul; 49(32):5426-45. PubMed ID: 20629054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical strategies in lipidomics and applications in disease biomarker discovery.
    Hu C; van der Heijden R; Wang M; van der Greef J; Hankemeier T; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2836-46. PubMed ID: 19233743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge discovery in metabolomics: an overview of MS data handling.
    Boccard J; Veuthey JL; Rudaz S
    J Sep Sci; 2010 Feb; 33(3):290-304. PubMed ID: 20087872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry: from proteomics to metabolomics and lipidomics.
    Griffiths WJ; Wang Y
    Chem Soc Rev; 2009 Jul; 38(7):1882-96. PubMed ID: 19551169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review.
    Roux A; Lison D; Junot C; Heilier JF
    Clin Biochem; 2011 Jan; 44(1):119-35. PubMed ID: 20800591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent advances in metabonomics].
    Xu GW; Lu X; Yang SL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):701-11. PubMed ID: 18595244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability-based biomarker selection.
    Wehrens R; Franceschi P; Vrhovsek U; Mattivi F
    Anal Chim Acta; 2011 Oct; 705(1-2):15-23. PubMed ID: 21962342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery.
    Elschenbroich S; Kislinger T
    Mol Biosyst; 2011 Feb; 7(2):292-303. PubMed ID: 20976349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and developments in tandem mass spectrometry based clinical metabolomics.
    Ceglarek U; Leichtle A; Brügel M; Kortz L; Brauer R; Bresler K; Thiery J; Fiedler GM
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):266-71. PubMed ID: 19007853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review.
    Smolinska A; Blanchet L; Buydens LM; Wijmenga SS
    Anal Chim Acta; 2012 Oct; 750():82-97. PubMed ID: 23062430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics for mass spectrometry-based metabolomics.
    Enot DP; Haas B; Weinberger KM
    Methods Mol Biol; 2011; 719():351-75. PubMed ID: 21370092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry-based technologies for high-throughput metabolomics.
    Han J; Datla R; Chan S; Borchers CH
    Bioanalysis; 2009 Dec; 1(9):1665-84. PubMed ID: 21083110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics: towards understanding traditional Chinese medicine.
    Zhang A; Sun H; Wang Z; Sun W; Wang P; Wang X
    Planta Med; 2010 Dec; 76(17):2026-35. PubMed ID: 21058239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical analytical approach for the identification of biomarker candidates in prediabetic state based upon metabonomic study by ultraperformance liquid chromatography coupled to electrospray ionization time-of-flight mass spectrometry.
    Tsutsui H; Maeda T; Toyo'oka T; Min JZ; Inagaki S; Higashi T; Kagawa Y
    J Proteome Res; 2010 Aug; 9(8):3912-22. PubMed ID: 20557141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expanding role of mass spectrometry in metabolite profiling and characterization.
    Want EJ; Cravatt BF; Siuzdak G
    Chembiochem; 2005 Nov; 6(11):1941-51. PubMed ID: 16206229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics.
    Gika HG; Theodoridis GA; Plumb RS; Wilson ID
    J Pharm Biomed Anal; 2014 Jan; 87():12-25. PubMed ID: 23916607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data processing pipelines for comprehensive profiling of proteomics samples by label-free LC-MS for biomarker discovery.
    Christin C; Bischoff R; Horvatovich P
    Talanta; 2011 Jan; 83(4):1209-24. PubMed ID: 21215856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MS-based plant metabolomic approaches for biomarker discovery.
    Wolfender JL; Glauser G; Boccard J; Rudaz S
    Nat Prod Commun; 2009 Oct; 4(10):1417-30. PubMed ID: 19911581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances of chromatography and mass spectrometry in lipidomics.
    Li M; Zhou Z; Nie H; Bai Y; Liu H
    Anal Bioanal Chem; 2011 Jan; 399(1):243-9. PubMed ID: 21052649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics.
    Want EJ; Nordström A; Morita H; Siuzdak G
    J Proteome Res; 2007 Feb; 6(2):459-68. PubMed ID: 17269703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.